Journal ArticleOPEN ACCESS

Antiangiogenic therapy combined with immune checkpoint blockade in urothelial cancer: Systematic review and meta-analysis

  • Moussa M
  • Kovalenko I
  • Crupi E
  • et al.
Bladder Cancer (2024) 10(4) 300-312
DOI: 10.1177/23523735241296763
N/ACitations
Citations of this article
3Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background Antiangiogenic therapy had been tested in urothelial cancer (UC) without reaching the clinic.Objective We provide a systematic review and meta-analysis of trials to assess efficacy of immune checkpoint inhibitors (ICI) combined with ...

Cite

CITATION STYLE

APA

Moussa, M. J., Kovalenko, I., Crupi, E., Proskuriakova, E., Geng, Y., Fallara, G., … Alhalabi, O. (2024). Antiangiogenic therapy combined with immune checkpoint blockade in urothelial cancer: Systematic review and meta-analysis. Bladder Cancer, 10(4), 300–312. https://doi.org/10.1177/23523735241296763

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free